Degli Esposti L, Perrone V, Sangiorgi D, Sinigaglia L. Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs. Reumatismo [Internet]. 2021 Apr. 19 [cited 2024 Nov. 22];73(1):5-14. Available from: https://www.reumatismo.org/reuma/article/view/1329